Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most ...

New real-world data suggest that two out of every five patients with transthyretin amyloid cardiomyopathy treated with ...

India's first heart failure registry reveals younger patients, high mortality rates, and varying causes of heart failure.

The European Commission has granted marketing authorization in the European Union (EU) for acoramidis, under the brand name ...

Pharma announced the European Commission has granted marketing authorization in the European Union for acoramidis, under the ...

Palo Alto, California Thursday, February 13, 2025, 12:00 Hrs [IST] ...

The Miracle League of Arizona, located in North Scottsdale, provides Arizona residents with disabilities the opportunity to play baseball. One of the members, Drew Boedigheimer, has a strong ...

hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and left ventricular noncompaction cardiomyopathy. They can be hereditary or acquired ...

Radiation-induced cardiomyopathy has become a significant clinical challenge with the increased use of thoracic radiation therapy. Recent technological advancements in radiation therapy, such as 3D ...